PGP and cancer: In a panel of normal and tumor cells that were primarily derived from the lung and prostate, we found that P-gp-associated drug-resistant (PacR and GefR) cancer cells express higher TUBB3 and FOXO3a levels compared to drug-sensitive normal cells.